Early infection in post-autologous hematopoietic stem cell transplant patients

References

1. 1.↵
   1. Hübel K,
   2. de la Rubia J,
   3. Azar N,
   4. Corradini P.

   Current status of haematopoietic autologous stem cell transplantation in lymphoid malignancies: a European perspective. Eur J of Haematol 2015; 94: 12–22.

   OpenUrl
2. 2.↵
   World Health Organization, International Agency for Research on Cancer, Saudi Arabia. The Global Cancer Observatory. [Updated 2021; accessed January 2021]. Available from: https://gco.iarc.fr/today/data/factsheets/populations/682-saudi-arabia-fact-sheets.pdf
3. 3.↵
   World Health Organization. Cancer Country Profile. [Updated 2014; accessed January 2021]. Available from: https://www.who.int/cancer/country-profiles/chn_en.pdf
4. 4.↵
   1. Gil L,
   2. Styczynski J,
   3. Komarnicki M.

   Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome. Infection 2007; 35: 421–427.

   OpenUrlPubMed
5. 5.↵
   1. Lakatos B,
   2. Szabó H,
   3. Csordás K,
   4. Tatai G,
   5. Nikolova R,
   6. Csomor J,
   7. Sinkó J.

   Epidemiology of early infections after autologous hematopoietic stem cell transplantation. Analysis of data from 699 patients treated in a Hungarian centre. Orv Hetil 2020; 161: 103.

   OpenUrl
6. 6.↵
   1. Girmenia C,
   2. Bertaina A,
   3. Piciocchi A,
   4. Perruccio K,
   5. Algarotti A,
   6. Busca A, et al.

   Incidence, risk factors and outcome of pre-engraftment gram-negative bacteremia after allogeneic and autologous hematopoietic stem cell transplantation: an Italian prospective multicenter survey. Clin Infect Dis 2017; 65: 1884–1896.

   OpenUrl
7. 7.↵
   1. Satlin MJ,
   2. Vardhana S,
   3. Soave R,
   4. Shore TB,
   5. Mark TM,
   6. Jacobs SE, et al.

   Impact of prophylactic levofloxacin on rates of bloodstream infection and fever in neutropenic patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2015; 21: 1808–1814.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Moghnieh R,
   2. Abdallah D,
   3. Awad L,
   4. Jisr T,
   5. Mugharbil A,
   6. Youssef A, et al.

   Bacteraemia post-autologous haematopoietic stem cell transplantation in the absence of antibacterial prophylaxis: a decade’s experience from Lebanon. Infection 2018; 46: 823–835.

   OpenUrl
9. 9.↵
   1. Valtola J,
   2. Varmavuo V,
   3. Ropponen A,
   4. Selander T,
   5. Kuittinen O,
   6. Kuitunen H, et al.

   Early immune recovery after autologous transplantation in non-Hodgkin lymphoma patients: predictive factors and clinical significance. Leuk Lymphoma 2016; 57: 2025–2032.

   OpenUrl
10. 10.↵
    1. Park H,
    2. Youk J,
    3. Kim HR,
    4. Koh Y,
    5. Kwon JH,
    6. Yoon SS, et al.

    Infectious complications in multiple myeloma receiving autologous stem cell transplantation in the past 10 years. Int J Hematol 2017; 106: 801–810.

    OpenUrl
11. 11.↵
    1. Ali N,
    2. Adil SN,
    3. Shaikh MU.

    Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country. Transpl Infect Dis 2014; 16: 98–105.

    OpenUrl
12. 12.↵
    1. Rahman S,
    2. Rybicki L,
    3. Ky Hamilton B,
    4. Pohlman B,
    5. Jagadeesh D,
    6. Cober E, et al.

    Early infectious complications after autologous hematopoietic cell transplantation for multiple myeloma.Transpl Infect Dis 2019; 21: e13114.

    OpenUrl
13. 13.↵
    1. Srinivasan A,
    2. McLaughlin L,
    3. Wang C,
    4. Srivastava DK,
    5. Shook DR,
    6. Leung W, et al.

    Early infections after autologous hematopoietic stem cell transplantation in children and adolescents: the St. Jude experience. Transpl Infec Dis 2014; 16: 90–97.

    OpenUrl
14. 14.↵
    1. Averbuch D,
    2. Tridello G,
    3. Hoek J,
    4. Mikulska M,
    5. Akan H,
    6. Yaňez San Segundo L, et al.

    Antimicrobial resistance in gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: intercontinental prospective study of the infectious diseases working party of the European bone marrow transplantation group. Clin Infect Dis 2017; 65: 1819–1828.

    OpenUrlCrossRef
15. 15.↵
    1. Hassan MN,
    2. Fauzi HM,
    3. Husin A,
    4. Mustaffa R,
    5. Hassan R,
    6. Ibrahim MI, et al.

    Autologous peripheral blood stem cell transplantation among lymphoproliferative disease patients: factors influencing engraftment. Oman Med J 2019; 34: 34–43.

    OpenUrl
16. 16.↵
    1. Nath K,
    2. Boles R,
    3. McCutchan A,
    4. Vangaveti V,
    5. Birchley A,
    6. Irving I.

    The relationship between CD34+ stem cell dose and time to neutrophil recovery in autologous haematopoietic stem cell recipients-A single centre experience. Transfus Apher Sci 2018; 57: 532–536.

    OpenUrl